Positive STING protein expression (H‐score > 50) was associated with significantly improved overall survival (58 vs. 35 months, p = 0.02) in a pooled NSCLC cohort, and a nonsignificant improve in overall survival when stratified according to histologies (AC: 57 vs. 37 months; SCC: 61 vs. 35 months). The gene discussed is STING1; the disease is non-small cell lung carcinoma.